[1]
L. I. Kucherenko and D. V. Okolzin, “The relevance of creating a new combined ophthalmic drug with anti-inflammatory and antibacterial effects”, Current issues in pharmacy and medicine: science and practice, vol. 18, no. 2, pp. 215–222, Jul. 2025.